Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Imageens logo — Building the future of clinical decision making in cardiovas...

Imageens

Building the future of clinical decision making in cardiovascular health with smart imaging biomarkers

Founded 2017 France France 5 employees Seed Total: $1.80M Medical Devices

General Information

Company Name Imageens
Founded Year 2017
Location France France +1
Employees 5
Industries Medical Devices
Funding Stage Seed
Social

Get notified when Imageens moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Imageens

Imageens is a French startup founded in 2017, dedicated to revolutionizing clinical decision-making in cardiovascular health through smart imaging biomarkers. The company's proprietary AI technology enables a deeper understanding of patients' cardiovascular risk. This revolutionary approach involves measuring new precision biomarkers, effectively addressing a range of unmet medical needs and leveraging cardiovascular imaging data. The recent milestone for Imageens was the successful completion of a €1.20M Seed Round investment on 15 April 2021, with the participation of bold Anaxago, bold Coalescence, and bold Les Business Angels des Grandes Écoles. With a mission to expand beyond cardiovascular prevention and ultimately transform and save lives across various clinical areas, Imageens is at the forefront of innovation in healthcare technology.

Taxonomy: AI clinical decision-making software, cardiovascular health, imaging biomarkers, precision medicine, medical imaging analysis, proprietary technology, biomarker measurement, patient risk assessment, medical software development, cloud-based medical technology, cardiovascular imaging data, diagnostic imaging AI, clinical decision support, medical device innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 3
Investor Investor Investor
15 Apr 2021
Angel Round •••••• 1
Investor
25 Jun 2019

Imageens Alternatives & Competitors

Imageens vs
Conavi Medical
Conavi Medical Canada

Advancing minimally invasive image-guidance technologies for medical procedures around the world

Series Unknown
68 employees
Health Care, Medical Devices
Imageens vs
Myogen
Myogen

Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.

Series D
Biopharma, Biotechnology
Imageens vs
InnerMedical
InnerMedical

Providing advanced diagnosis and treatment solutions for major diseases with innovative endoscopic a...

Series D
11 employees
Health Care

FAQ About Imageens

Building the future of clinical decision making in cardiovascular health with smart imaging biomarkers
Imageens was founded in 2017.
Imageens is headquartered in France.
Imageens operates in the following industries: Medical Devices.
Imageens has approximately 5 employees.
Imageens has completed 2 funding rounds, raising a total of $1.80M. The latest funding stage is Seed.
Top alternatives and competitors to Imageens include Conavi Medical, Myogen, InnerMedical, CASIS - CArdiac Simulation & Imaging Software, Hi-D Imaging. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Imageens and Conavi Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Imageens and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy